查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1532952

光学成像市场：2024-2029 年预测

Optical Imaging Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

光学成像市场预计将从 2024 年的 29.39 亿美元增加到 2029 年的 46.67 亿美元，复合年增长率为 9.69%。

光学成像使用光捕获身体组织和细胞的图像，然后从组织成分和生物分子过程推断资讯。它使用从紫外线到近红外光的光子来产生图像。有多种类型，例如光同调断层扫瞄（OCT）、内视镜检查和光声成像。

此类影像主要被研究人员、生物技术人员和药剂师用于小动物模型研究和临床应用，例如癌症和淋巴瘤检测、妇科恶性研究、体内影像、DNA研究、新生儿和成人脑部影像。光学成像借助非电离辐射减少患者接触有害辐射的机会。它广泛应用于生物医学研究和医学。

光学成像市场驱动因素：

  • 生物医学和生物製药研究的加速成长预计将推动市场扩张

光学成像是一项重要技术，可为研究人员、药剂师和生物技术人员提供研究复杂的人类、动物和植物模型的有用资讯。生物医学、生物製药和医疗保健（尤其是眼科）的研究正在促进光学影像市场的成长。根据美国职业安全与健康研究所（NIOSH）的报告，美国每天约有 2000 名工人遭受与工作相关的眼外伤并需要治疗。

  • 慢性病增加加速市场扩张

准确的青光眼筛检需要使用新的光学成像技术进行早期诊断和治疗，以阻止进展为失明。活体成像，特别是全身活体成像，可以研究人类疾病的动物模型，减少动物实验的比例，为科学研究提供必要的资讯。 Vivo 成像的其他应用包括微生物学中使用的生物发光和临床研究中常用的 Vivo 成像萤光方法。

  • 新科技发展加速市场拓展

例如，CT（电脑断层扫描）、MRI（磁振造影）和PET-CT（位置发射断层扫描-电脑断层扫描）等新技术发展广泛应用于医学影像技术。此外，也推出了新软体来增强光学成像。例如，2023年10月，雅培实验室发布了Ultreon 1.0，这是一款整合了人工智慧和光学相干断层扫描（OCT）的血管成像软体。

研究人员正在研究 3D 光学成像和 3D 显示在医学、机器人、安全、检测、视觉化和显示功能等领域的应用。例如，3D医学影像是一项改善诊所和手术室疾病预防、诊断和治疗的新技术。光学成像生物发光、化学冷光发光、余辉成像以及使用具有宏观介观区域的NIR-II探针的成像探针是深层组织成像研究的新进展。

限制光学成像市场的因素：

  • 缺乏临床专业知识限制了市场成长

光学成像为疾病检测和癌症治疗提供了巨大的潜力。然而，最佳成像、吸收和散射问题的普遍性较低，以及临床设备和专业知识的缺乏可能会阻碍光学成像市场的成长。

光学成像市场的地域展望

  • 预测期内，北美将占据光学成像市场的主要份额

由于研究和技术进步不断增加，以及主要应用光学成像进行更好诊断的眼、脑、癌症和其他疾病的扩散，预计北美将占据重要的市场占有率。此外，Heidelberg Engineering Inc.、Carl Zeiss Meditec、Bruker Corporation 和 Leica Microsystems 等市场参与企业的成熟存在也对该地区的市场成长产生了积极影响。

区域经济体，即美国，视力障碍的盛行率很高。根据美国疾病管制与预防中心 (CDC) 的数据，美国40 岁以上的人中约有 1,200 万人患有视力丧失，其中近 800 万人仍未接受治疗。主要眼疾包括青光眼、糖尿病性视网膜病变、白内障和屈光不正。

脑部疾病，主要是阿兹海默症、脑肿瘤、失智症和帕金森氏症，是造成美国许多人死亡的原因。此外，核磁共振扫描是一种用于检测大脑影像并推断结果的技术。乳癌和脑肿瘤是美国癌症相关死亡的主要原因之一。

电脑断层扫描 (PET-CT) 扫描和发射断层扫描等影像技术用于更准确地确定癌症的阶段及其在体内扩散的程度。此外，人工智慧等新技术也被引入医学成像应用，为光学成像提供了新的成长前景。

此外，除了在医疗应用方面具有巨大潜力外，光学成像也正在进入太空任务，美国太空总署等主要太空机构正在投资此类技术。

光学成像市场的主要发展

  • 2024 年 4 月：Spectral Instruments Imaging 宣布推出最新版本的 Vivo 光学成像软体「Aura 4.5」。基于精确的自动化和专有的动力学模式演算法捕获和分析即时动态生物发光讯号。
  • 2024 年 2 月：布鲁克公司宣布收购 Spectral Instruments Imaging LLC，这是临床前体内光学影像系统开发专家。此次收购将使布鲁克能够扩大其用于疾病研究的 BioSpin 临床前成像部门。
  • 2023 年 10 月：雅培实验室宣布在印度推出新型血管影像软体「Ultreon 1.0」。全球首款结合人工智慧和光学相干断层扫描 (OCT) 的血管内影像软体，可为医生提供冠状动脉闭塞和血流的全面视图。
  • 2023 年 9 月：Revvity Inc. 推出 IVIS(R) Spectrum 2、IVIS SpectrumCT 2 和 Quantum GX3 microCT 影像系统，旨在推动临床前研究方法的创新。这些标准产品旨在提高体内和体外领域的灵敏度水平。 光学成像。
  • 2023 年 9 月：Yole 集团合作伙伴 PISEO 宣布推出光学影像测试服务。这些服务使用可靠、最先进的设备来表征高付加医疗领域的整个光学成像链。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章光学成像市场：依技术分类

  • 介绍
  • 内视镜检查
  • 光学同调断层扫描(OCT)
  • 光声成像
  • 拉曼光谱
  • 超高解析度显微镜（SRM）
  • 漫射光学断层扫描 (DOT)

第六章光学影像市场：依应用分类

  • 介绍
  • 眼科
  • 瘤
  • 牙科
  • 皮肤科
  • 神经
  • 其他的

第七章光学成像市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 以色列
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 印度
    • 印尼
    • 台湾
    • 其他的

第八章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第九章 公司简介

  • ZEISS Group
  • Leica Microsystems
  • Topcon Corporation
  • Heidelberg Engineering GmbH
  • Santec Corporation
  • Luneau Technology USA
  • Headwall Photonics
  • Koninklijke Philips NV
  • NIDEK CO., LTD.
简介目录
Product Code: KSI061610434

The optical imaging market is poised to reach US$4.667 billion in 2029 from estimated value of US$2.939 billion in 2024 at 9.69% (CAGR).

Optical imaging uses light to obtain images of body tissue or cells, before which the information is deduced from tissue composition and biomolecular processes. It generates images using photons of light from ultraviolet to near-infrared. Such imaging comprises various types, such as optical coherence tomography (OCT), endoscopy, and photoacoustic imaging, among others.

Optical Imaging is primarily used by researchers, biotechnicians, and pharmacists to study small animal models and clinical applications, such as the detection of cancer and lymphoma, the study of gynaecologic malignancies, in vivo imaging, research on DNA, neonatal and adult brain imaging, and other applications. Optimal Imaging reduces a patient's exposure to harmful radiation with the help of non-ionizing radiation. It is widely used in biomedical research and medical care.

Optical Imaging Market Drivers:

  • Bolstering growth in biomedical and biopharmaceutical research is expected to propel the market expansion.

Optical imaging is an essential technique that provides useful information to researchers, pharmacists, and biotechnicians for studying complex human, animal, and plant models. Research in biomedical, biopharmaceutical, and medical care, especially in eye care, is contributing to the optical imaging market's growth. The National Institute for Occupational Safety and Health (NIOSH) reports that about 2000 US workers suffer from job-related eye injuries daily that require medical treatment.

  • Growing chronic disease prevalence has accelerated the market expansion.

Accurate glaucoma screening requires using novel optical imaging techniques for early diagnosis and treatment that would stop the progression to blindness. Vivo imaging, particularly whole-body Vivo imaging, enables the study of animal models of human diseases, reducing the rate of experimentation on animals and providing essential information in research studies. Other applications of Vivo imaging can be seen in bioluminescence, which is used in microbiology, and fluorescence methods in vivo imaging, which are commonly used in clinical research.

  • New technological developments are accelerating the market expansion.

New developments in optical imaging techniques, for instance, CT (Computed Tomography), MRI (Magnetic Resonance Imaging), and PET-CT (Position Emission Tomography - Computed Tomography), are widely applied in medical imaging techniques. Additionally, new software launches to bolster optical imaging are also taking place. For instance, Abbott Laboratories, in October 2023, launched its vascular imaging software "Ultreon 1.0", which integrates Artificial Intelligence and optical coherence tomography (OCT), which enables physicians to get a comprehensive view of coronary arteries.

Researchers have researched 3D optical imaging and 3D display, with applications in medicine, robotics, security, detection, visualization, and display abilities. For example, 3D medical imaging is a new technology that can improve disease prevention, diagnosis, and treatment in clinics and operating rooms. Optical imaging through imaging probes using bioluminescence, chemiluminescence, afterglow imaging, and NIR-II probes having macro-mesoscopic regimes are new advances in studying deep tissue imaging.

Optical Imaging Market Restraints:

  • Lack of clinical expertise is expected to restrain the market growth.

Optical imaging provides a major scope for disease detection and cancer care. However, the low penetration of optimal imaging, absorption, and scattering issues, and the lack of clinical instrumentation and expertise will likely hamper the optical imaging market's growth.

Optical Imaging Market Geographical Outlook

  • During the forecast period, North America is expected to hold a significant share of the optical imaging market.

North America is projected to account for a considerable market share due to increased research and technological advancements, and the surge in eye, brain, cancer, and other diseases, where optical imaging is majorly applied for better diagnosis. Well-established presence of market players, namely Heidelberg Engineering Inc., Carl Zeiss Meditec, Bruker Corporation, Leica Microsystems, and others, has also positively impacted the regional market growth.

Regional economies, namely the USA, are experiencing a high prevalence of vision impairment cases. According to the CDC ( Centres for Disease Control and Prevention), approximately 12 million people 40 years and above suffer from vision impairment in the United States, of which nearly 8 million cases remain untreated. Major eye diseases include Glaucoma, Diabetic Retinopathy, Cataracts, and Refractive Error.

Brain Diseases, mainly Alzheimer's, Brain Tumour, Dementia, and Parkinson's Disease, are resulting in deaths among people in the United States. Further, MRI Scanning is a technique used to detect images from the brain and deduce results. Breast and brain cancer constitutes one of the major cancer-related deaths in the US.

To better determine the cancer stages and their spread level within the body, imaging techniques such as Computed Tomography (PET-CT) Scans and Emission Tomography are used. Furthermore, emerging technologies such as Artificial Intelligence are also finding their way into medical imaging applications, providing new growth prospects for optical imaging.

Moreover, besides high applicability in the medical sector, optical imaging is also finding its way into space missions, where major space organizations such as NASA are investing in such technology.

Optical Imaging Market Key Developments

  • April 2024: Spectral Instruments Imaging launched the latest version of its vivo optical imaging software, "Aura 4.5". It is based on precise automation and a proprietary "Kinetics Mode" algorithm for capturing and analyzing real-time dynamic bioluminescent signals.
  • February 2024: Bruker Corporation announced the acquisition of Spectral Instruments Imaging LLC, a specialist in developing pre-clinical in-vivo optical imaging systems. The acquisition would enable Bruker to extend its "BioSpin Preclinical Imaging" division for disease research.
  • October 2023: Abbott Laboratories announced the launch of its new vascular imaging software, "Ultreon 1.0", in India. The first-of-its-kind intravascular imaging software combines Artificial Intelligence and Optical Coherence Tomography (OCT) to enable physicians to get a comprehensive view of blockage and blood flow in the coronary arteries.
  • September 2023: Revvity Inc. launched the " IVIS(R) Spectrum 2", "IVIS SpectrumCT 2", and "Quantum GX3 microCT" imaging systems, which aimed to drive innovations across the preclinical research process. The standard products aimed to elevate the sensitivity standard of both in-vivo and ex-vivo optical imaging.
  • September 2023: Yole Group's partner, PISEO, announced the launch of its optical imaging testing services. These services would use cutting-edge equipment that is reliable for the characterization of the entire optical imaging chain in high-value-added medical areas.

The Optical Imaging market is segmented and analyzed as follows:

By Technique

  • Endoscopy
  • Optical Coherence Tomography (OCT)
  • Photoacoustic Imaging
  • Raman Spectroscopy
  • Super-Resolution Microscopy
  • Diffuse Optical Topography

By Application

  • Ophthalmology
  • Oncology
  • Dentistry
  • Dermatology
  • Neurology
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. OPTICAL IMAGING MARKET BY TECHNIQUE

  • 5.1. Introduction
  • 5.2. Endoscopy
  • 5.3. Optical Coherence Tomography (OCT)
  • 5.4. Photoacoustic Imaging
  • 5.5. Raman Spectroscopy
  • 5.6. Super-Resolution Microscopy
  • 5.7. Diffuse Optical Tomography (DOT)

6. OPTICAL IMAGING MARKET BY APPLICATIONS

  • 6.1. Introduction
  • 6.2. Ophthalmology
  • 6.3. Oncology
  • 6.4. Dentistry
  • 6.5. Dermatology
  • 6.6. Neurology
  • 6.7. Others

7. OPTICAL IMAGING MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. Israel
    • 7.5.3. UAE
    • 7.5.4. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. Japan
    • 7.6.3. South Korea
    • 7.6.4. India
    • 7.6.5. Indonesia
    • 7.6.6. Taiwan
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. ZEISS Group
  • 9.2. Leica Microsystems
  • 9.3. Topcon Corporation
  • 9.4. Heidelberg Engineering GmbH
  • 9.5. Santec Corporation
  • 9.6. Luneau Technology USA
  • 9.7. Headwall Photonics
  • 9.8. Koninklijke Philips N.V.
  • 9.9. NIDEK CO., LTD.